Data / Form D filings / NexPoint Life Sciences II DST
NexPoint Life Sciences II DST: Form D filings
NexPoint Life Sciences II DST, a real estate company in Dallas, TX, filed 19 Form D notices with the SEC between 2023 and 2025. The latest, on November 20, 2025, reports $40.5 million sold of a $40.5 million offering to 112 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 300 CRESCENT COURT, SUITE 700, Dallas, TX, 75201
- Phone
- (833) 697-6246
- Industry
- Other Real Estate
- Entity type
- Other (Delaware Statutory Trust)
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c), Investment Company Act section 3(c), 3C.5
- SEC identifier (CIK)
- 1980223
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | Amendment | $40,489,695 | $40,489,695 | 112 | Jun 20, 2023 | sec.gov | |
| Nov 7, 2025 | Amendment | $40,489,695 | $39,563,756 | $925,939 | 109 | Jun 20, 2023 | sec.gov |
| Sep 9, 2025 | Amendment | $40,489,695 | $36,996,318 | $3,493,377 | 105 | Jun 20, 2023 | sec.gov |
| Apr 21, 2025 | Amendment | $40,489,695 | $31,059,027 | $9,430,668 | 89 | Jun 20, 2023 | sec.gov |
| Dec 17, 2024 | Amendment | $40,489,695 | $29,030,796 | $11,458,899 | 79 | Jun 20, 2023 | sec.gov |
| Oct 30, 2024 | Amendment | $40,489,695 | $27,864,030 | $12,625,665 | 75 | Jun 20, 2023 | sec.gov |
| May 29, 2024 | Amendment | $40,489,695 | $19,431,177 | $21,058,518 | 58 | Jun 20, 2023 | sec.gov |
| Apr 22, 2024 | Amendment | $40,489,695 | $19,409,113 | $21,080,582 | 54 | Jun 20, 2023 | sec.gov |
| Apr 9, 2024 | Amendment | $40,489,695 | $18,798,171 | $21,691,524 | 53 | Jun 20, 2023 | sec.gov |
| Dec 13, 2023 | Amendment | $40,489,695 | $11,282,417 | $29,207,278 | 37 | Jun 20, 2023 | sec.gov |
| Nov 30, 2023 | Amendment | $40,489,695 | $10,188,242 | $30,301,453 | 34 | Jun 20, 2023 | sec.gov |
| Nov 15, 2023 | Amendment | $40,489,695 | $9,731,859 | $30,757,836 | 32 | Jun 20, 2023 | sec.gov |
| Oct 18, 2023 | Amendment | $40,489,695 | $7,669,777 | $32,819,918 | 22 | Jun 20, 2023 | sec.gov |
| Sep 26, 2023 | Amendment | $40,489,695 | $6,330,757 | $34,158,938 | 17 | Jun 20, 2023 | sec.gov |
| Sep 14, 2023 | Amendment | $40,489,695 | $2,827,397 | $37,662,298 | 13 | Jun 20, 2023 | sec.gov |
| Aug 18, 2023 | Amendment | $40,489,695 | $1,760,707 | $38,728,988 | 8 | Jun 20, 2023 | sec.gov |
| Jul 20, 2023 | Amendment | $40,489,695 | $999,222 | $39,490,473 | 5 | Jun 20, 2023 | sec.gov |
| Jul 7, 2023 | Amendment | $40,489,695 | $521,380 | $39,968,315 | 2 | Jun 20, 2023 | sec.gov |
| Jun 22, 2023 | New notice | $40,489,695 | $421,380 | $40,068,315 | 1 | Jun 20, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| N/A NREA Life Sciences II, LLC | Executive Officer | |
| N/A NREA LS II Investment Co, LLC | Executive Officer | |
| Matt McGraner | Executive Officer | |
| Matthew Goetz | Executive Officer | |
| N/A NexPoint Real Estate Advisors IV, L.P. | Executive Officer |
Other real estate companies in Texas that filed recently
- Mobile Home Park Investors LLC $1.2 million · Nov 2, 2026
- Rycore TX Industrial Holdings LLC $3.8 million · Oct 30, 2026
- Rycore Point West Venture LLC $1.3 million · Oct 30, 2026
- Rycore TX Service Center Holdings LLC $1.5 million · Oct 30, 2026
- Beacon Hospitality Fund I LLC offering · Oct 29, 2026
- NexPoint Marina II DST $16.5 million · Oct 28, 2026
Every Form D from the week of Nov 17, 2025 · All recent filings in Texas · All recent Other Real Estate filings
Read from SEC EDGAR. Amount sold is what NexPoint Life Sciences II DST reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.